Blood analysis data.
The hemogram of controls and patients before and after treatment with
FVIII is shown in Table 2 (suppl). There were no differences between
controls and patients in any variable, although leucocytes and
lymphocytes number was significantly lower after administering FVIII to
HA patients. Similarly, mean platelet volume was also significantly
decreased in FVIII-treated HA patients. The data obtained in the special
coagulation study are shown in Table 3 (suppl). As expected, we observed
statistically significant differences in the amount of FVIII before and
after FVIII infusion, as well as with control subjects (p
<0.001). In the rest of the parameters, VWF:Ag and VWF:Rco, no
significant differences were observed between groups.